All data are based on the daily closing price as of February 10, 2026
l
L&C Bio
290650.KQ
60.50 USD
2.40
+4.13%
Overview
Last close
60.50 usd
Market cap
1.49B usd
52 week high
64.77 usd
52 week low
10.84 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
26.8725
Price/Book Value
8.0963
Enterprise Value
1.45B usd
EV/Revenue
26.5876
EV/EBITDA
14.57
Key financials
Revenue TTM
51.93M usd
Gross Profit TTM
25.52M usd
EBITDA TTM
3.88M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
355.50M usd
Net debt
45.16M usd
About
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea.